Bio-Techne Corporation Share Price & Technical Analysis
TECH · $48.01 (-0.41%)
Healthcare / Biotechnology
$48.01
-0.41%
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspe…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-13% return in May, 3% avg return in past 3 year May month.
-15% return in 2026, -5% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 9% | -7% | -10% | 6% | -13% | – | – | – | – | – | – | – | -15% |
| 25 | 1% | -14% | -5% | -13% | -3% | 8% | 7% | 1% | 3% | 13% | 4% | -8% | -7% |
| 24 | -8% | 10% | -4% | -11% | 10% | -8% | 14% | -10% | 9% | -8% | 2% | -4% | -9% |
| 23 | -5% | -9% | 3% | 8% | 2% | 0% | 3% | -6% | -14% | -20% | 15% | 23% | 0% |
| 22 | -27% | 3% | 3% | -13% | -2% | -6% | 11% | -13% | -14% | 4% | 19% | -3% | -38% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$7.54B
P/E ratio
68.83
52W high
$72.16
52W low
$43.20
Volume
2,32,506
Beta
1.41
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Bio-Techne Corporation share price today?
- Bio-Techne Corporation (TECH) last traded around $48.01 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does TECH have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for TECH. Download the app for real-time alerts.
- How can I analyze Bio-Techne Corporation stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.